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TOWARDS AN UNDERSTANDING OF ALZHEIMER'S DISEASE II: 
THE VULNERABILITY HYPOTHESIS: DO GLUCOCORTICOIDS INCREASE 
CHOLINERGIC SUSCEPTIBILITY TO NEURAL TOXINS? 
Heather A. Lang, Edmund C. Schweitzer and Wayne A. Dornan*, 
Department of Psychology, IWU. 
Alzheimer's disease (AD) is a neurodegenerative disorder, currently affecting over 4 
million Americans, with 100,000 new cases reported each year. AD is broadly characterized by a 
global and progressive deterioration of memory, cognition, and personality. The most evident 
clinical symptom of AD is memory loss. Studies in humans and rats report a significant 
correlation between this memory loss and a decline in cholinergic markers, such as choline 
acetyltransferase (ChAT) levels in the cerebral cortex and hippocampus. Therefore, one approach 
towad developing an animal model of AD is to induce lesions in the hippocampus. This was 
attempted in a number of studies, including one by Chrobak, Hanin, Schmechel, and Walsh 
(I988), in which lesioning of the hippocampus produced acetylcholine deficits, as measured by 
lower ChAT levels, which in turn produced behavioral deficits. Recently, it has been found that 
high concentrations of cortisol are linked to neuronal loss in AD. This postulate is a result of 
accumulating evidence suggesting that hypercortisolemia and a decreased negative feedback 
inhibition of cortisol secretion frequently accompany AD. In a recent study by Hortnagi, Berger, 
Havelec, and Hornykiewicz (1993) they reported that, when injected bilaterally into the lateral 
ventricles, the neurotoxin ethyicholine aziridinium (AF64A) induced specific reduction of ChAT 
activity throughout the hippocampus. In that same study, Hortnagl investigated the role of 
giucocorticoids in the cholinergic degeneration brought about by bilateral intracerebroventricular 
injections of AF64A (1 nmollventricle). They reported that chronic glucocorticoid administration 
seven days before surgery potentiates the susceptibility of cholinergic neurons to AF64A-induced 
deterioration. Though Hortnagl and colleagues explored the neurophysiological effects of 
glucocorticoid-potentiated AF64A toxicity, they did not explore the behavioral implications of 
these injections. Therefore, in the current study we investigated the effects of 
intracerebroventricular injections of AF64A on spatial learning in male rats chronically treated 
with glucocorticoids. Four groups were compared: group one, AF64A plus sesame oil; group 
two, AF64A plus corticosterone; group three, saline plus sesame oil; and group four, saline plus 
corticosterone. These groups were subjected to a visual discrimination task involving both a fixed 
and a floating platform in the Morris water maze. To assess the effects of the above injections, 
several parameters were measured: path length, swim speed, session latency, and choice errors. 
The results of this study will be presented at the conference. 
